Arcutis’s Zoryve Succeeds In Second Phase III In Atopic Dermatitis

 
• By Joseph Haas
  
Atopic dermatitis
Arcutis moves toward adding AD to the Zoryve label • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D